Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Getsinger Peter W	Director	2026-06-23	2K shares	$1.40M
Griffin William F Jr	Director	2026-06-22	20K shares	$15.33M
Griffin William F Jr	Director	2026-06-18	30K shares	$21.98M
Getsinger Peter W	Director	2026-06-17	2K shares	$1.40M
Sweeney Karen	Director	2026-06-17	300 shares	$209K
Baugher Joshua Scott	Officer	2026-06-17	760 shares	$529K
Getsinger Peter W	Director	2026-06-16	5K shares	$3.35M
Watson David Hibbert	Officer, Director	2026-06-16	2K shares	$1.30M
Watson David Hibbert	Officer, Director	2026-06-15	10K shares	$6.57M
Flanders Cynthia	DIRECTOR	2026-06-12	3K shares	$1.61M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ARGAN INC (AGX)?

Major stakeholders currently include BlackRock, Inc. ($1.2B), First Trust Advisors LP ($431.0M), Renaissance Technologies LLC ($332.7M). Based on the latest 13F filings, there are a total of 489 tracked investment funds and institutions maintaining positions in AGX.

What is the overall institutional sentiment toward AGX recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $3.1B, driven by 277 managers accumulating shares while 229 reduced their exposure.

Which institutions have been selling or reducing their AGX positions?

In the latest period, 164 funds trimmed their holdings, and 65 managers completely exited their positions. The aggregate reported sell value was $1.8B.

Are there any notable investors adding AGX to their portfolios?

Yes, buying activity remains notable. 128 institutions opened new positions in {ticker}, and 149 existing holders added to their shares. The total reported buy value for the quarter amounted to $5.4B.